Life-course adiposity and severe liver disease: a Mendelian randomization analysis

Obesity (Silver Spring). 2023 Dec;31(12):3077-3085. doi: 10.1002/oby.23913. Epub 2023 Oct 23.

Abstract

Objective: There is little evidence on the genetic associations between life-course adiposity (including birth weight, childhood BMI, and adulthood BMI) and severe liver disease (SLD; including cirrhosis and liver cancer). The current study aimed to examine and contrast these associations.

Methods: Genetic variants were obtained from genome-wide association studies. Two-sample Mendelian randomization (MR) analyses were performed to assess the genetic associations of life-course adiposity with SLD and liver biomarkers. Cox regression was used to estimate adjusted hazard ratios for SLD associated with genetic risk scores of life-course adiposity and adulthood weight change in the China Kadoorie Biobank.

Results: In observational analyses, genetic predispositions to childhood adiposity and adulthood adiposity were each associated with SLD. There was a U-shaped association between adulthood weight change and risk of SLD. In meta-analyses of MR results, genetically predicted 1-standard deviation increase in birth weight was inversely associated with SLD at a marginal significance (odds ratio: 0.81 [95% CI: 0.65-1.00]), whereas genetically predicted 1-standard deviation higher childhood BMI and adulthood BMI were positively associated with SLD (odds ratio: 1.27 [95% CI: 1.05-1.55] and 1.79 [95% CI: 1.59-2.01], respectively). The results of liver biomarkers mirrored those of SLD.

Conclusions: The current study provided genetic evidence on the associations between life-course adiposity and SLD.

MeSH terms

  • Adiposity / genetics
  • Biomarkers
  • Birth Weight / genetics
  • Body Mass Index
  • Child
  • Genome-Wide Association Study
  • Humans
  • Liver Diseases* / complications
  • Mendelian Randomization Analysis / methods
  • Pediatric Obesity* / complications
  • Polymorphism, Single Nucleotide

Substances

  • Biomarkers